Skip to content
Search

Latest Stories

India to soon make available 10m Covid-19 vaccine doses per day

India to soon make available 10m Covid-19 vaccine doses per day

INDIA could have as many as 10 million doses of Covid-19 vaccines available per day in July and August, compared with just under three million now, the government said, trying to allay concerns about shortages and mishandling of the programme.

The world's second most populous country has suffered a disastrous outbreak of infections since April that is only now abating and health experts say the only way it can avert another surge is mass vaccination of its 1.3 billion people.


India on Wednesday (2) reported a daily rise in new coronavirus infections of 132,788 cases over the past 24 hours, while deaths rose by 3,207.

"We don’t doubt that we will be able to increase the pace of vaccinations, once supply is ramped up," government advisor V K Paul told reporters.

Vaccine manufacturers such as Serum Institute of India and Bharat Biotech are scrambling to boost supplies, with the country is also in talks with major foreign vaccine producers such as Pfizer Inc, officials have said.

The health ministry said nearly 45 million people had been fully vaccinated - 4.7 per cent of the country's 950 million adult population. India administered nearly 2.8 million doses on Monday, according to data from its official vaccine portal.

Prime Minister Narendra Modi's government has drawn criticism for a slow vaccine rollout even though India is one of the world's biggest manufacturers of doses, including AstraZeneca's shot.

Several states have complained of a shortage of the AstraZenca vaccines and another called Covaxin, developed by Indian firm Bharat Biotech.

Last month, the government ordered that the interval between two doses of AstraZeneca be increased to 12-16 weeks from 4-6 weeks, which experts said was because of tight supplies.

Paul said there was no plan to mix doses of different vaccines that some officials had suggested earlier. He also said everyone was recommended to take the full two doses of AstraZeneca's vaccine and not limit themselves to one shot.

"India's Covishield schedule is of two doses... there is no change, and Covaxin is also for two doses," Paul said.

Balram Bhargava, head of the Indian Council of Medical Research, said: "Containment has worked. However, it is not a sustainable solution and we have to find a measure to ease the lockdowns."

The South Asian nation's tally of infections now stands at 28.3 million, while the death toll has reached 335,102, health ministry data showed.

More For You

Spotting the signs of dementia

Priya Mulji with her father

Spotting the signs of dementia

How noticing the changes in my father taught me the importance of early action, patience, and love

I don’t understand people who don’t talk or see their parents often. Unless they have done something to ruin your lives or you had a traumatic childhood, there is no reason you shouldn’t be checking in with them at least every few days if you don’t live with them.

Keep ReadingShow less
HH Guruji performed the Dhwaja Ritual at Ambaji Temple

HH Guruji performed the Dhwaja Ritual at Ambaji Temple

Mahesh Liloriya

The holy town of Ambaji witnessed a spiritually significant day on Sunday as His Holiness Siri Rajrajeshwar Guruji, head of the International Siddhashram Shakti Centre, London, performed the Dhwaja ritual at the historic Ambaji Temple in Gujarat, one of the most revered Shakti Peeths of India.

Keep ReadingShow less
Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Eco-friendly Ganesh Utsav at Harrow’s Siddhashram Shakti Centre

Mahesh Liloriya

The International Siddhashram Shakti Centre in Harrow witnessed an inspiring and environmentally responsible celebration of Ganesh Utsav 2025, which concluded on Saturday, 6 September, with the Ganesh Visarjan ritual performed on the sacred occasion of Anant Chaturdashi.

Keep ReadingShow less
Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less